Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity.
Spina
E
E
Scordo
M G
MG
Avenoso
A
A
Perucca
E
E
D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D019389:Cytochrome P-450 CYP2D6 / Q000172:deficiency / Q000378:metabolism*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000201:enzymology*
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D002220:Carbamazepine; D019389:Cytochrome P-450 CYP2D6; D018967:Risperidone